GlassScriptPhysician profile
Indermohan Luthra
NPI 1598795668
$13,485.25
in general payments reported to CMS, 2019-2025
69 companies · $2,627 in 2025
The $2,627 reported for 2025 was more than what 77% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,500 · 2020: $597 · 2021: $2,897 · 2022: $1,314 · 2023: $1,754 · 2024: $1,795 · 2025: $2,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,830 · Travel and Lodging: $330 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,830.36 |
| Travel and Lodging | $329.56 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,507.33 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Abbvie INC. | $967.10 | 2019-2025 | |
| Livanova USA, INC. | $799.59 | 2020-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Argenx US, INC. | $799.52 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $761.98 | 2019-2025 | Zilbrysq, Rystiggo |
| Pfizer INC. | $619.87 | 2021-2025 | |
| Eisai INC. | $500.88 | 2019-2025 | |
| Medtronic USA, INC. | $495.35 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $448.34 | 2019-2025 | Austedo Xr, Austedo Xr |
| Abbott Laboratories | $428.97 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $359.56 | 2019-2025 | Ultomiris |
| Neurocrine Biosciences, INC. | $351.99 | 2019-2025 | Ingrezza |
| Novartis Pharmaceuticals Corporation | $295.16 | 2019-2025 | |
| Emd Serono, INC. | $290.25 | 2019-2022 | |
| Novo Nordisk INC | $237.09 | 2024-2025 | Wegovy |
Show all 69 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Indermohan Luthra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.